{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:07:40Z","timestamp":1791216460189,"version":"4.1.0"},"reference-count":324,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University Hospital of the Vrije Universiteit Brussel-Belgium"},{"name":"Fund for Scientific Research-Flanders","award":["G009514N"],"award-info":[{"award-number":["G009514N"]}]},{"name":"Fund for Scientific Research-Flanders","award":["G010214N"],"award-info":[{"award-number":["G010214N"]}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["335476"],"award-info":[{"award-number":["335476"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of S\u00e3o Paulo-Brazil"},{"DOI":"10.13039\/501100001807","name":"Foundation for Research Support of the State of S\u00e3o Paulo","doi-asserted-by":"crossref","award":["2013\/50420-6"],"award-info":[{"award-number":["2013\/50420-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Lipid Research"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.plipres.2015.05.002","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T23:41:23Z","timestamp":1434238883000},"page":"106-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":157,"special_numbering":"C","title":["Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research"],"prefix":"10.1016","volume":"59","author":[{"given":"Joost","family":"Willebrords","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Veloso Alves","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Crespo Yanguas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Colle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Van Den Bossche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza Cristina","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia Pinto Marques Souza","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wellington","family":"Andraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ven\u00e2ncio Avancini","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Cogliati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Vinken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plipres.2015.05.002_b0005","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0010","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.plipres.2015.05.002_b0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000336669","article-title":"Nonalcoholic fatty liver disease\/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment","volume":"30","author":"Mili\u0107","year":"2012","journal-title":"Dig. Dis."},{"key":"10.1016\/j.plipres.2015.05.002_b0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1665-2681(19)32110-6","article-title":"Fatty liver: how frequent is it and why?","volume":"3","author":"Bedogni","year":"2004","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0025","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/00042737-200411000-00002","article-title":"The epidemiology of fatty liver","volume":"16","author":"Bellentani","year":"2004","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0029-1240004","article-title":"The natural history of drug-induced liver injury","volume":"29","author":"Bj\u00f6rnsson","year":"2009","journal-title":"Semin. Liver Dis."},{"issue":"Suppl 1","key":"10.1016\/j.plipres.2015.05.002_b0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jgh.12212","article-title":"Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches","volume":"28","author":"Schuppan","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0040","doi-asserted-by":"crossref","first-page":"145754","DOI":"10.1155\/2012\/145754","article-title":"Diagnosis and evaluation of nonalcoholic fatty liver disease","volume":"2012","author":"Obika","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.plipres.2015.05.002_b0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/dmrr.1198","article-title":"Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do","volume":"27","author":"Lebovics","year":"2011","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.plipres.2015.05.002_b0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1751-2980.2010.00471.x","article-title":"Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis","volume":"12","author":"Adams","year":"2011","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.plipres.2015.05.002_b0055","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00428-011-1066-1","article-title":"Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease","volume":"458","author":"Tannapfel","year":"2011","journal-title":"Virchows Arch."},{"key":"10.1016\/j.plipres.2015.05.002_b0060","first-page":"1041","article-title":"Hepatic steatosis background in chronic hepatitis B and C - significance of similarities and differences","volume":"55","author":"Moro\u015fan","year":"2014","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.plipres.2015.05.002_b0065","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0070","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","article-title":"Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.plipres.2015.05.002_b0075","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/cncr.28730","article-title":"The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review","volume":"120","author":"Fong","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.plipres.2015.05.002_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2013.09.019","article-title":"Obesity and liver disease: the epidemic of the twenty-first century","volume":"18","author":"Corey","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.plipres.2015.05.002_b0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s001470050852","article-title":"A comparison of the costs and effects of liver transplantation for acute and for chronic liver failure","volume":"14","author":"van Agthoven","year":"2001","journal-title":"Transpl. Int."},{"key":"10.1016\/j.plipres.2015.05.002_b0090","doi-asserted-by":"crossref","first-page":"44507","DOI":"10.1074\/jbc.M207712200","article-title":"The surface of lipid droplets is a phospholipid monolayer with a unique Fatty Acid composition","volume":"277","author":"Tauchi-Sato","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plipres.2015.05.002_b0095","first-page":"246","article-title":"Diagnosis and interpretation of steatosis and steatohepatitis","volume":"15","author":"Burt","year":"1998","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.plipres.2015.05.002_b0100","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.plipres.2015.05.002_b0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/bega.2002.0333","article-title":"Pathogenesis of steatohepatitis","volume":"16","author":"Day","year":"2002","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.plipres.2015.05.002_b0110","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1381\/0960892053723493","article-title":"Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) \u2013 preliminary findings","volume":"15","author":"Oliveira","year":"2005","journal-title":"Obes. Surg."},{"key":"10.1016\/j.plipres.2015.05.002_b0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/CS20030285","article-title":"Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients","volume":"106","author":"Videla","year":"2004","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.plipres.2015.05.002_b0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4067\/S0716-97602008000100008","article-title":"Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease","volume":"41","author":"Elizondo","year":"2008","journal-title":"Biol. Res."},{"key":"10.1016\/j.plipres.2015.05.002_b0125","first-page":"441","article-title":"Molecular mechanisms of steatosis in nonalcoholic fatty liver disease","volume":"26","author":"Pettinelli","year":"2011","journal-title":"Nutr. Hosp."},{"key":"10.1016\/j.plipres.2015.05.002_b0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1478-3231.2007.01483.x","article-title":"Current concepts in the pathogenesis of nonalcoholic fatty liver disease","volume":"27","author":"M\u00e9ndez-S\u00e1nchez","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.plipres.2015.05.002_b0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2005.09.002","article-title":"Non-alcoholic steatohepatitis: from cell biology to clinical practice","volume":"44","author":"Cortez-Pinto","year":"2006","journal-title":"J. Hepatol."},{"issue":"Suppl 1","key":"10.1016\/j.plipres.2015.05.002_b0140","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1665-2681(19)31822-8","article-title":"Metabolic syndrome and non-alcoholic fatty liver disease","volume":"8","author":"Almeda-Vald\u00e9s","year":"2009","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0145","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.CIR.0000112379.88385.67","article-title":"Clinical management of metabolic syndrome: report of the American Heart Association\/National Heart, Lung, and Blood Institute\/American Diabetes Association conference on scientific issues related to management","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2015.05.002_b0150","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.plipres.2015.05.002_b0155","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrgastro.2010.21","article-title":"Pathology of nonalcoholic fatty liver disease","volume":"7","author":"Brunt","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0160","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbalip.2012.08.013","article-title":"Drug induced phospholipidosis: an acquired lysosomal storage disorder","volume":"1831","author":"Shayman","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plipres.2015.05.002_b0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol."},{"key":"10.1016\/j.plipres.2015.05.002_b0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/17512433.2014.871202","article-title":"Evidence for a potential protective effect of carnitine\u2013pantothenic acid co-treatment on valproic acid-induced hepatotoxicity","volume":"7","author":"Felker","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0175","first-page":"365","article-title":"Brief history of the development of valproate in bipolar disorders","volume":"27","author":"Lemp\u00e9ri\u00e8re","year":"2001","journal-title":"Encephale"},{"key":"10.1016\/j.plipres.2015.05.002_b0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1399-5618.2003.00031.x","article-title":"Valproate","volume":"5","author":"Bowden","year":"2003","journal-title":"Bipolar Disord."},{"issue":"Suppl","key":"10.1016\/j.plipres.2015.05.002_b0185","first-page":"30","article-title":"Phenomenology of rapid cycling manic depression and its treatment with valproate","volume":"50","author":"Calabrese","year":"1989","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.plipres.2015.05.002_b0190","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archpedi.1982.03970420050011","article-title":"Valproic acid in the treatment of intractable absence seizures in children: a single-blind clinical and quantitative EEG study","volume":"136","author":"Erenberg","year":"1982","journal-title":"Am. J. Dis. Child"},{"key":"10.1016\/j.plipres.2015.05.002_b0195","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.0013-9580.2004.40903.x","article-title":"Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study","volume":"45","author":"Coppola","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.plipres.2015.05.002_b0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1528-1157.1988.tb04409.x","article-title":"Valproate monotherapy in 30 patients with partial seizures","volume":"29","author":"Dean","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.plipres.2015.05.002_b0205","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1059-1311(00)90530-2","article-title":"Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate","volume":"10","author":"Calleja","year":"2001","journal-title":"Seizure"},{"key":"10.1016\/j.plipres.2015.05.002_b0210","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plipres.2015.05.002_b0215","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reactions induced by valproic acid","volume":"46","author":"Nanau","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.plipres.2015.05.002_b0220","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/0006-2952(83)90054-0","article-title":"The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats","volume":"32","author":"Turnbull","year":"1983","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0225","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/0006-2952(92)90324-C","article-title":"In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions","volume":"43","author":"Ponchaut","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0230","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0006-291X(85)91014-9","article-title":"Inhibition of medium-chain fatty acid beta-oxidation in vitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid","volume":"132","author":"Bjorge","year":"1985","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plipres.2015.05.002_b0235","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.taap.2007.09.014","article-title":"Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver","volume":"226","author":"Lee","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0240","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.107.131185","article-title":"Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores","volume":"324","author":"Knapp","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plipres.2015.05.002_b0245","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/j.1552-4604.1983.tb02722.x","article-title":"The toxicity of metabolites of sodium valproate in cultured hepatocytes","volume":"23","author":"Kingsley","year":"1983","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0250","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.1840040610","article-title":"The hepatotoxicity of valproic acid and its metabolites in rats. II. Intermediary and valproic acid metabolism","volume":"4","author":"Granneman","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b0255","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.1840040609","article-title":"The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies","volume":"4","author":"Kesterson","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b0260","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0090-9556(25)07155-7","article-title":"Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans","volume":"19","author":"Kassahun","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.plipres.2015.05.002_b0265","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0022-3565(24)37076-4","article-title":"Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acid","volume":"283","author":"Sadeque","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plipres.2015.05.002_b0270","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0005-2728(98)00112-1","article-title":"The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy","volume":"1366","author":"Lemasters","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plipres.2015.05.002_b0275","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.bcp.2009.10.011","article-title":"Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis","volume":"79","author":"Aires","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0280","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.hrtlng.2013.05.004","article-title":"Amiodarone-induced pulmonary toxicity: case study with syndrome analysis","volume":"42","author":"Van Cott","year":"2013","journal-title":"Heart Lung"},{"key":"10.1016\/j.plipres.2015.05.002_b0285","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/qjmed\/hcq131","article-title":"Amiodarone-induced skin hyperpigmentation","volume":"104","author":"St\u00e4hli","year":"2011","journal-title":"QJM"},{"key":"10.1016\/j.plipres.2015.05.002_b0290","first-page":"359","article-title":"Amiodarone-induced thyroid dysfunction\u2013clinical picture. Study on 215 cases","volume":"118","author":"Preda","year":"2014","journal-title":"Rev. Med. Chir. Soc. Med. Nat. Iasi"},{"key":"10.1016\/j.plipres.2015.05.002_b0295","article-title":"Fatal acute liver failure after intravenous amiodarone administration","author":"Li","year":"2013","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.plipres.2015.05.002_b0300","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0022-3565(25)22984-6","article-title":"Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice","volume":"255","author":"Fromenty","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plipres.2015.05.002_b0305","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11886-013-0410-2","article-title":"Antiarrhythmic drugs 2013: state of the art","volume":"15","author":"Kumar","year":"2013","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.plipres.2015.05.002_b0310","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/187152910790780032","article-title":"Amiodarone \u2013 a \u2018broad spectrum\u2019 antiarrhythmic drug","volume":"10","author":"Punnam","year":"2010","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"10.1016\/j.plipres.2015.05.002_b0315","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1124\/jpet.104.072785","article-title":"Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation","volume":"311","author":"McCarthy","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plipres.2015.05.002_b0320","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/hep.1840190422","article-title":"Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions","volume":"19","author":"Deschamps","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b0325","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0006-2952(02)01660-X","article-title":"Concentration dependent mitochondrial effect of amiodarone","volume":"65","author":"Varbiro","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0330","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0005-2760(96)00168-3","article-title":"Microsomal triglyceride transfer protein","volume":"1345","author":"Wetterau","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plipres.2015.05.002_b0335","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/toxsci\/kfs298","article-title":"Mechanisms of hepatocellular toxicity associated with dronedarone\u2013a comparison to amiodarone","volume":"131","author":"Felser","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.plipres.2015.05.002_b0340","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.plipres.2015.05.002_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/S1089-3261(03)00021-7","article-title":"Hepatotoxicity of antibiotics and antifungals","volume":"7","author":"Thiim","year":"2003","journal-title":"Clin. Liver. Dis."},{"key":"10.1016\/j.plipres.2015.05.002_b0350","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/MEG.0b013e3282f493c5","article-title":"Minocycline hepatitis","volume":"20","author":"Ford","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0355","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/toxsci\/kfl078","article-title":"Hepatic gene expression profiling and lipid homeostasis in mice exposed to steatogenic drug, tetracycline","volume":"94","author":"Yin","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.plipres.2015.05.002_b0360","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tox.2009.04.058","article-title":"Protective effect of bicyclol on tetracycline-induced fatty liver in mice","volume":"261","author":"Yu","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.plipres.2015.05.002_b0365","first-page":"551","article-title":"The effect of terramycin on the fine structure of HeLa cell mitochondria","volume":"23","author":"Journey","year":"1963","journal-title":"Cancer Res."},{"key":"10.1016\/j.plipres.2015.05.002_b0370","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1126\/science.133.3447.196","article-title":"Selective localization of tetracycline in mitochondria of living cells","volume":"133","author":"Du Buy","year":"1961","journal-title":"Science"},{"key":"10.1016\/j.plipres.2015.05.002_b0375","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJM196311072691903","article-title":"Fatal liver disease after intravenous administration of tetracycline in high dosage","volume":"269","author":"Schultz","year":"1963","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.plipres.2015.05.002_b0380","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0002-9610(67)90308-X","article-title":"Tetracycline-induced fatty liver in nonpregnant patients. A report of six cases","volume":"113","author":"Peters","year":"1967","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.plipres.2015.05.002_b0385","doi-asserted-by":"crossref","first-page":"C539","DOI":"10.1152\/ajpcell.00047.2010","article-title":"Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature","volume":"299","author":"Griffin","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.plipres.2015.05.002_b0390","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/oxfordjournals.annonc.a010715","article-title":"The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study","volume":"7","author":"Chang","year":"1996","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.plipres.2015.05.002_b0395","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/cncr.20900","article-title":"Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina","volume":"103","author":"Bradbury","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.plipres.2015.05.002_b0400","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.plipres.2015.05.002_b0405","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","author":"(EBCTCG) EBCTCG","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2015.05.002_b0410","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2214\/ajr.180.1.1800129","article-title":"Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy","volume":"180","author":"Nishino","year":"2003","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.plipres.2015.05.002_b0415","first-page":"1299","article-title":"Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients","volume":"7","author":"Murata","year":"2000","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.plipres.2015.05.002_b0420","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(05)74872-8","article-title":"Cirrhosis with steatohepatitis after adjuvant tamoxifen","volume":"353","author":"Oien","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2015.05.002_b0425","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.toxlet.2010.10.008","article-title":"Gene expression profiling of murine hepatic steatosis induced by tamoxifen","volume":"199","author":"Lee","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.plipres.2015.05.002_b0430","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1194\/jlr.M600148-JLR200","article-title":"Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver","volume":"47","author":"Gudbrandsen","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plipres.2015.05.002_b0435","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/taap.2001.9265","article-title":"Mechanisms of the deleterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency","volume":"176","author":"Cardoso","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0440","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1007695308257","article-title":"Effects of tamoxifen on the electron transport chain of isolated rat liver mitochondria","volume":"16","author":"Tuquet","year":"2000","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.plipres.2015.05.002_b0445","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1542\/peds.66.6.859","article-title":"Reye\u2019s syndrome and salicylate use","volume":"66","author":"Starko","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.plipres.2015.05.002_b0450","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0140-6736(63)90554-3","article-title":"Encephalopathy and fatty degeneration of the viscera. A disease entity in childhood","volume":"2","author":"Reye","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2015.05.002_b0455","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/0003-9861(82)90056-X","article-title":"Reye\u2019s syndrome: plasma-induced alterations in mitochondrial structure and function","volume":"214","author":"Segalman","year":"1982","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.plipres.2015.05.002_b0460","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.6857275","article-title":"Salicylate and mitochondrial injury in Reye\u2019s syndrome","volume":"221","author":"You","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.plipres.2015.05.002_b0465","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0003-9861(86)90646-6","article-title":"Reye\u2019s syndrome: mitochondrial swelling and Ca2+ release induced by Reye\u2019s plasma, allantoin, and salicylate","volume":"244","author":"Martens","year":"1986","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.plipres.2015.05.002_b0470","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0006-2952(98)00342-6","article-title":"Stereoselective and substrate-dependent inhibition of hepatic mitochondria beta-oxidation and oxidative phosphorylation by the non-steroidal anti-inflammatory drugs ibuprofen, flurbiprofen, and ketorolac","volume":"57","author":"Browne","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0475","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3565(25)22933-0","article-title":"Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids","volume":"255","author":"Freneaux","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plipres.2015.05.002_b0480","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/jhep.2003.50309","article-title":"Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice","volume":"38","author":"Lett\u00e9ron","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b0485","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1124\/jpet.106.104125","article-title":"The anti-inflammatory drug, nimesulide (4-nitro-2-phenoxymethane-sulfoanilide), uncouples mitochondria and induces mitochondrial permeability transition in human hepatoma cells: protection by albumin","volume":"318","author":"Berson","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plipres.2015.05.002_b0490","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11010-010-0689-x","article-title":"Inhibition of mitochondrial respiratory chain in the brain of rats after hepatic failure induced by acetaminophen","volume":"350","author":"Panatto","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.plipres.2015.05.002_b0495","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1172\/JCI59755","article-title":"The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation","volume":"122","author":"McGill","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plipres.2015.05.002_b0500","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2004.09.015","article-title":"Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice","volume":"42","author":"Masubuchi","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0505","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","author":"Roubille","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.plipres.2015.05.002_b0510","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4292\/wjgpt.v5.i3.113","article-title":"Use of methotrexate in inflammatory bowel disease in 2014: a user\u2019s guide","volume":"5","author":"Swaminath","year":"2014","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"10.1016\/j.plipres.2015.05.002_b0515","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00210-006-0040-y","article-title":"Pharmacogenomics of human OATP transporters","volume":"372","author":"K\u00f6nig","year":"2006","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0520","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1177\/0960327113515503","article-title":"Mitochondrial dysfunction and respiratory chain defects in a rodent model of methotrexate-induced enteritis","volume":"33","author":"Kolli","year":"2014","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.plipres.2015.05.002_b0525","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.2008.058248","article-title":"Histological patterns in drug-induced liver disease","volume":"62","author":"Ramachandran","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.plipres.2015.05.002_b0530","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.plipres.2015.05.002_b0535","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0022-3565(25)13428-9","article-title":"Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice","volume":"247","author":"Le Dinh","year":"1988","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.plipres.2015.05.002_b0540","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/0006-2952(89)90580-7","article-title":"Tianeptine, a new tricyclic antidepressant metabolized by beta-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice","volume":"38","author":"Fromenty","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0545","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.tiv.2008.01.011","article-title":"High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes","volume":"22","author":"Igoudjil","year":"2008","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.plipres.2015.05.002_b0550","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.20074","article-title":"Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine","volume":"39","author":"Walker","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b0555","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0006-2952(96)00204-3","article-title":"Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone","volume":"52","author":"Kennedy","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0560","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/gut.20.3.186","article-title":"Liver damage associated with perhexiline maleate","volume":"20","author":"Lewis","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.plipres.2015.05.002_b0565","first-page":"590","article-title":"Induction of fatty liver in the rat after cycloheximide administration","volume":"23","author":"Jazcilevich","year":"1970","journal-title":"Lab. Invest."},{"key":"10.1016\/j.plipres.2015.05.002_b0570","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/0006-2952(79)90444-1","article-title":"Mechanism of the fatty liver induced by cycloheximide and its reversibility by adenosine","volume":"28","author":"Garc\u00eda-S\u00e1inz","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0575","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0005-2760(72)90109-9","article-title":"Mulitiple effects of cycloheximide on the metabolism of triglycerides in the liver of male and female rats","volume":"270","author":"Bar-On","year":"1972","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plipres.2015.05.002_b0580","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1872-034X.2011.00791.x","article-title":"Major role of apolipoprotein B in cycloheximide-induced acute hepatic steatosis in mice","volume":"41","author":"Murakami","year":"2011","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.plipres.2015.05.002_b0585","first-page":"327","article-title":"The effect of prolonged administration of disulfiram alone or in combination with ethanol on some indices of lipid metabolism in the blood serum and hepatic tissue of the rat","volume":"32","author":"Mach","year":"1980","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.plipres.2015.05.002_b0590","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0009-2797(01)00283-6","article-title":"Mitochondrial injury by disulfiram: two different mechanisms of the mitochondrial permeability transition","volume":"138","author":"Balakirev","year":"2001","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.plipres.2015.05.002_b0595","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0020-711X(93)90493-X","article-title":"Deleterious effects of disulfiram on the respiratory electron transport system of liver mitochondria","volume":"25","author":"Kuroda","year":"1993","journal-title":"Int. J. Biochem."},{"key":"10.1016\/j.plipres.2015.05.002_b0600","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0166-3542(96)01027-3","article-title":"Fialuridine is phosphorylated and inhibits DNA synthesis in isolated rat hepatic mitochondria","volume":"34","author":"Horn","year":"1997","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.plipres.2015.05.002_b0605","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0022-3565(24)29292-2","article-title":"Toxicity of alpidem, a peripheral benzodiazepine receptor ligand, but not zolpidem, in rat hepatocytes: role of mitochondrial permeability transition and metabolic activation","volume":"299","author":"Berson","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plipres.2015.05.002_b0610","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-3565(25)22351-5","article-title":"Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen","volume":"270","author":"Berson","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plipres.2015.05.002_b0615","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.taap.2009.07.021","article-title":"Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes","volume":"240","author":"Rachek","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0620","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.taap.2010.08.007","article-title":"Multiple mechanisms underlying troglitazone-induced mitochondrial permeability transition","volume":"248","author":"Okuda","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0625","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1471-4159.2011.07636.x","article-title":"Tacrine and its analogues impair mitochondrial function and bioenergetics: a lipidomic analysis in rat brain","volume":"120","author":"Melo","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.plipres.2015.05.002_b0630","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/jhep.2003.50353","article-title":"Tacrine inhibits topoisomerases and DNA synthesis to cause mitochondrial DNA depletion and apoptosis in mouse liver","volume":"38","author":"Mansouri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b0635","first-page":"1456","article-title":"Et al.","volume":"34","author":"Tanaka","year":"1985","journal-title":"Masui"},{"key":"10.1016\/j.plipres.2015.05.002_b0640","first-page":"61","article-title":"Study of steatosis induced in the rat by orotic acid","volume":"19","author":"Feo","year":"1973","journal-title":"Biomedicine"},{"key":"10.1016\/j.plipres.2015.05.002_b0645","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/jpet.107.124024","article-title":"Impaired microsomal oxidation of the atypical antipsychotic agent clozapine in hepatic steatosis","volume":"322","author":"Zhang","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plipres.2015.05.002_b0650","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10620-011-1931-4","article-title":"The effect of taurine on hepatic steatosis induced by thioacetamide in zebrafish (Danio rerio)","volume":"57","author":"Hammes","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.plipres.2015.05.002_b0655","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","article-title":"Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"18","author":"Takahashi","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.plipres.2015.05.002_b0660","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.3390\/ijms140611963","article-title":"In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)","volume":"14","author":"Kanuri","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.plipres.2015.05.002_b0665","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.alcohol.2004.08.005","article-title":"Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease","volume":"34","author":"Nanji","year":"2004","journal-title":"Alcohol"},{"key":"10.1016\/j.plipres.2015.05.002_b0670","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1743-7075-7-24","article-title":"High levels of dietary stearate promote adiposity and deteriorate hepatic insulin sensitivity","volume":"7","author":"van den Berg","year":"2010","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.plipres.2015.05.002_b0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","article-title":"Mouse models in non-alcoholic fatty liver disease and steatohepatitis research","volume":"87","author":"Anstee","year":"2006","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.plipres.2015.05.002_b0680","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis","volume":"105","author":"Leclercq","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plipres.2015.05.002_b0685","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jhep.2008.03.026","article-title":"MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes","volume":"49","author":"Larter","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0690","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","author":"Rinella","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plipres.2015.05.002_b0695","first-page":"233","article-title":"Commonly used animal models of non-alcoholic steatohepatitis","volume":"8","author":"Fan","year":"2009","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.plipres.2015.05.002_b0700","doi-asserted-by":"crossref","first-page":"e97136","DOI":"10.1371\/journal.pone.0097136","article-title":"HCC development is associated to peripheral insulin resistance in a mouse model of NASH","volume":"9","author":"De Minicis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2015.05.002_b0705","doi-asserted-by":"crossref","first-page":"216S","DOI":"10.1093\/jn\/137.1.216S","article-title":"Methyl deficiency, alterations in global histone modifications, and carcinogenesis","volume":"137","author":"Pogribny","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.plipres.2015.05.002_b0710","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jhep.2009.03.021","article-title":"Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet","volume":"51","author":"Pogribny","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0715","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.HYP.0000164570.20420.67","article-title":"Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction","volume":"45","author":"Ackerman","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.plipres.2015.05.002_b0720","doi-asserted-by":"crossref","DOI":"10.1002\/hep.23122","article-title":"Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice","volume":"50","author":"Spruss","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b0725","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.3945\/jn.109.105858","article-title":"Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis","volume":"139","author":"Kawasaki","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.plipres.2015.05.002_b0730","doi-asserted-by":"crossref","first-page":"21873","DOI":"10.3390\/ijms141121873","article-title":"Hepatic adverse effects of fructose consumption independent of overweight\/obesity","volume":"14","author":"Schultz","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.plipres.2015.05.002_b0735","doi-asserted-by":"crossref","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","article-title":"Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition","volume":"301","author":"Charlton","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.plipres.2015.05.002_b0740","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.bbamem.2014.01.007","article-title":"Membrane composition and dynamics: a target of bioactive virgin olive oil constituents","volume":"1838","author":"Lopez","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plipres.2015.05.002_b0745","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ejcn.2012.124","article-title":"INSIG2 variants, dietary patterns and metabolic risk in Samoa","volume":"67","author":"Baylin","year":"2013","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.plipres.2015.05.002_b0750","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/oby.2010.137","article-title":"Comparison of the relative contributions of intra-abdominal and liver fat to components of the metabolic syndrome","volume":"19","author":"Kotronen","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.plipres.2015.05.002_b0755","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/ajcn\/76.6.1222","article-title":"Fatty acid composition of skeletal muscle reflects dietary fat composition in humans","volume":"76","author":"Andersson","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plipres.2015.05.002_b0760","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/BF02544583","article-title":"Phospholipid content and fatty acid composition of human heart","volume":"24","author":"Rocquelin","year":"1989","journal-title":"Lipids"},{"key":"10.1016\/j.plipres.2015.05.002_b0765","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11239-008-0198-x","article-title":"Co-existence of fatty acids changes in aorta artery and adipose tissue; comparison between CAD and non CAD patients","volume":"27","author":"Bahrami","year":"2009","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.plipres.2015.05.002_b0770","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11064-009-0087-5","article-title":"Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer\u2019s disease","volume":"35","author":"Fraser","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.plipres.2015.05.002_b0775","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1476-511X-12-79","article-title":"Relationship between central and peripheral fatty acids in humans","volume":"12","author":"Guest","year":"2013","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.plipres.2015.05.002_b0780","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/CS20030326","article-title":"Increase in long-chain polyunsaturated fatty acid n - 6\/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease","volume":"106","author":"Araya","year":"2004","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.plipres.2015.05.002_b0785","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/geno.2000.6191","article-title":"The human fatty acid transport protein-1 (SLC27A1; FATP-1) cDNA and gene: organization, chromosomal localization, and expression","volume":"66","author":"Martin","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.plipres.2015.05.002_b0790","doi-asserted-by":"crossref","first-page":"G855","DOI":"10.1152\/ajpgi.00434.2009","article-title":"Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob\/ob or db\/db mice","volume":"299","author":"Ge","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.plipres.2015.05.002_b0795","doi-asserted-by":"crossref","first-page":"14456","DOI":"10.1016\/S0021-9258(19)49734-2","article-title":"Adipocyte differentiation of 3T3-L1 cells involves augmented expression of a 43-kDa plasma membrane fatty acid-binding protein","volume":"267","author":"Zhou","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plipres.2015.05.002_b0800","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3181\/00379727-208-43854","article-title":"Mitochondrial aspartate aminotransferase expressed on the surface of 3T3-L1 adipocytes mediates saturable fatty acid uptake","volume":"208","author":"Zhou","year":"1995","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.plipres.2015.05.002_b0805","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/bbrc.1998.0123","article-title":"Identification of caveolin-1 as a fatty acid binding protein","volume":"255","author":"Trigatti","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plipres.2015.05.002_b0810","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-3-642-00663-0_11","article-title":"Mitochondrial involvement in drug-induced liver injury","author":"Pessayre","year":"2010","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0815","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/labinvest.3700590","article-title":"Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes","volume":"87","author":"De Gottardi","year":"2007","journal-title":"Lab. Invest."},{"key":"10.1016\/j.plipres.2015.05.002_b0820","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/pr.108.00001","article-title":"Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis","volume":"60","author":"Anderson","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.plipres.2015.05.002_b0825","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plipres.2015.05.002_b0830","doi-asserted-by":"crossref","first-page":"G194","DOI":"10.1152\/ajpgi.00413.2005","article-title":"Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis","volume":"290","author":"Bradbury","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.plipres.2015.05.002_b0835","doi-asserted-by":"crossref","first-page":"396","DOI":"10.5483\/BMBRep.2012.45.7.070","article-title":"Central energy metabolism remains robust in acute steatotic hepatocytes challenged by a high free fatty acid load","volume":"45","author":"Niklas","year":"2012","journal-title":"BMB Rep."},{"key":"10.1016\/j.plipres.2015.05.002_b0840","first-page":"95","article-title":"Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells","volume":"2","author":"Cui","year":"2010","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.plipres.2015.05.002_b0845","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1016\/j.ejmech.2011.07.031","article-title":"Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis invitro","volume":"46","author":"Zhang","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.plipres.2015.05.002_b0850","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.fct.2013.04.018","article-title":"Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH) via modulation of PPAR\u03b1 and SREBP-1","volume":"58","author":"Ziamajidi","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.plipres.2015.05.002_b0855","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1046\/j.1440-1746.2003.03198.x","article-title":"Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies","volume":"18","author":"Kirsch","year":"2003","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0860","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0023677212473717","article-title":"Gender and strain-specific differences in the development of steatosis in rats","volume":"47","author":"St\u00f6ppeler","year":"2013","journal-title":"Lab. Anim."},{"key":"10.1016\/j.plipres.2015.05.002_b0865","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(96)80030-4","article-title":"Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice","volume":"24","author":"Letteron","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0870","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/toxsci\/kfi184","article-title":"Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats","volume":"86","author":"Tong","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.plipres.2015.05.002_b0875","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40268-014-0042-z","article-title":"Valproate-induced liver injury: modulation by the omega-3 fatty acid DHA proposes a novel anticonvulsant regimen","volume":"14","author":"Abdel-Dayem","year":"2014","journal-title":"Drugs R D"},{"key":"10.1016\/j.plipres.2015.05.002_b0880","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.taap.2006.12.016","article-title":"Gene expression profiles of murine fatty liver induced by the administration of valproic acid","volume":"220","author":"Lee","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0885","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1440-1746.2006.04313.x","article-title":"Oxidative stress in experimental liver microvesicular steatosis: role of mitochondria and peroxisomes","volume":"21","author":"Natarajan","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0890","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00280-014-2434-8","article-title":"Chemotherapy-associated steatohepatitis induced by irinotecan: a novel animal model","volume":"74","author":"Costa","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b0895","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/dvdy.21559","article-title":"Adiponectin and adiponectin receptor genes are coexpressed during zebrafish embryogenesis and regulated by food deprivation","volume":"237","author":"Nishio","year":"2008","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.plipres.2015.05.002_b0900","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00418-002-0434-y","article-title":"Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio)","volume":"118","author":"Ibabe","year":"2002","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.plipres.2015.05.002_b0905","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11373-005-9055-5","article-title":"Thioacetamide induced liver damage in zebrafish embryo as a disease model for steatohepatitis","volume":"13","author":"Amali","year":"2006","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.plipres.2015.05.002_b0910","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/zeb.2012.0821","article-title":"Defining hepatic dysfunction parameters in two models of fatty liver disease in zebrafish larvae","volume":"10","author":"Howarth","year":"2013","journal-title":"Zebrafish"},{"key":"10.1016\/j.plipres.2015.05.002_b0915","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1743-7075-8-88","article-title":"Transcriptome analysis of anti-fatty liver action by Campari tomato using a zebrafish diet-induced obesity model","volume":"8","author":"Tainaka","year":"2011","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.plipres.2015.05.002_b0920","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1038\/srep03708","article-title":"Eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis","volume":"4","author":"Hiramitsu","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.plipres.2015.05.002_b0925","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.27284","article-title":"Fructose leads to hepatic steatosis in zebrafish that is reversed by mechanistic target of rapamycin (mTOR) inhibition","volume":"60","author":"Sapp","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b0930","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1100\/tsw.2007.117","article-title":"The physiology of obese-hyperglycemic mice [Ob\/ob mice]","volume":"7","author":"Lindstr\u00f6m","year":"2007","journal-title":"Sci. World J."},{"key":"10.1016\/j.plipres.2015.05.002_b0935","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1073\/pnas.94.6.2557","article-title":"Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis","volume":"94","author":"Yang","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.plipres.2015.05.002_b0940","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s10620-007-0193-7","article-title":"The transition from fatty liver to NASH associates with SAMe depletion in db\/db mice fed a methionine choline-deficient diet","volume":"53","author":"Wortham","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.plipres.2015.05.002_b0945","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1101\/gad.7.7b.1318","article-title":"Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity","volume":"7","author":"Ross","year":"1993","journal-title":"Genes Dev."},{"key":"10.1016\/j.plipres.2015.05.002_b0950","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1172\/JCI118951","article-title":"Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a","volume":"98","author":"Shimano","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plipres.2015.05.002_b0955","doi-asserted-by":"crossref","first-page":"35832","DOI":"10.1074\/jbc.274.50.35832","article-title":"Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes","volume":"274","author":"Shimano","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plipres.2015.05.002_b0960","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2015.05.002_b0965","doi-asserted-by":"crossref","first-page":"19055","DOI":"10.1074\/jbc.274.27.19055","article-title":"A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism","volume":"274","author":"Febbraio","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plipres.2015.05.002_b0970","doi-asserted-by":"crossref","first-page":"17839","DOI":"10.3748\/wjg.v20.i47.17839","article-title":"Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis","volume":"20","author":"Simon","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.plipres.2015.05.002_b0975","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0002-9440(10)61770-1","article-title":"Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis","volume":"159","author":"Lu","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.plipres.2015.05.002_b0980","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gutjnl-2013-305736","article-title":"The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62\/IGF2BP2-2 as a promoter of NAFLD and HCC?","volume":"63","author":"Simon","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.plipres.2015.05.002_b0985","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jhep.2010.08.034","article-title":"Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype","volume":"54","author":"Tybl","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b0990","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.3748\/wjg.v19.i41.6969","article-title":"PNPLA3 I148M polymorphism and progressive liver disease","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.plipres.2015.05.002_b0995","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b1000","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1017\/S0007114514001986","article-title":"A high-protein diet is anti-steatotic and has no pro-inflammatory side effects in dyslipidaemic APOE2 knock-in mice","volume":"112","author":"Garcia Caraballo","year":"2014","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.plipres.2015.05.002_b1005","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/hep.26551","article-title":"Homeostatic generation of reactive oxygen species protects the zebrafish liver from steatosis","volume":"58","author":"Nussbaum","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b1010","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s11248-012-9685-0","article-title":"Cannabinoid receptor 1 promotes hepatic lipid accumulation and lipotoxicity through the induction of SREBP-1c expression in zebrafish","volume":"22","author":"Pai","year":"2013","journal-title":"Transgenic Res."},{"key":"10.1016\/j.plipres.2015.05.002_b1015","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bbalip.2013.02.002","article-title":"Ubiquitous transcription factor YY1 promotes zebrafish liver steatosis and lipotoxicity by inhibiting CHOP-10 expression","volume":"1831","author":"Her","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plipres.2015.05.002_b1020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jhep.2006.06.004","article-title":"ER stress: can the liver cope?","volume":"45","author":"Ji","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b1025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/hep.24349","article-title":"Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish","volume":"54","author":"Thakur","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b1030","first-page":"229","article-title":"Isolation of rat hepatocytes","volume":"320","author":"Papeleu","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.plipres.2015.05.002_b1035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2249.2011.04471.x","article-title":"Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease","volume":"166","author":"Tang","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.plipres.2015.05.002_b1040","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/j.1478-3231.2010.02298.x","article-title":"Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes","volume":"30","author":"De Gottardi","year":"2010","journal-title":"Liver Int."},{"key":"10.1016\/j.plipres.2015.05.002_b1045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cbi.2006.11.004","article-title":"A human hepatocellular in vitro model to investigate steatosis","volume":"165","author":"G\u00f3mez-Lech\u00f3n","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.plipres.2015.05.002_b1050","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/jat.1420","article-title":"In vitro assay for drug-induced hepatosteatosis using rat primary hepatocytes, a fluorescent lipid analog and gene expression analysis","volume":"29","author":"Fujimura","year":"2009","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.plipres.2015.05.002_b1055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60761-688-7_1","article-title":"General review on in vitro hepatocyte models and their applications","volume":"640","author":"Guguen-Guillouzo","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.plipres.2015.05.002_b1060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.tiv.2006.07.008","article-title":"Effects of steatosis on drug-metabolizing capability of primary human hepatocytes","volume":"21","author":"Donato","year":"2007","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.plipres.2015.05.002_b1065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0005-2760(95)00006-X","article-title":"Differential effects of eicosapentaenoic acid on glycerolipid and apolipoprotein B metabolism in primary human hepatocytes compared to HepG2 cells and primary rat hepatocytes","volume":"1256","author":"Lin","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plipres.2015.05.002_b1070","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2174\/1389200211314090002","article-title":"Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering","volume":"14","author":"Donato","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.plipres.2015.05.002_b1075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.6248960","article-title":"Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen","volume":"209","author":"Knowles","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.plipres.2015.05.002_b1080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-2275(20)38686-7","article-title":"Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin","volume":"28","author":"Dashti","year":"1987","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plipres.2015.05.002_b1085","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11626-013-9646-9","article-title":"Suppression of Grb2 expression improved hepatic steatosis, oxidative stress, and apoptosis induced by palmitic acid in vitro partly through insulin signaling alteration","volume":"49","author":"Shan","year":"2013","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.plipres.2015.05.002_b1090","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.3390\/ijms15034019","article-title":"The effect and mechanism of tamoxifen-induced hepatocyte steatosis in vitro","volume":"15","author":"Zhao","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.plipres.2015.05.002_b1095","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.tiv.2011.05.011","article-title":"Cellular glutathione in fatty liver in vitro models","volume":"25","author":"Garcia","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.plipres.2015.05.002_b1100","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/hep.24290","article-title":"Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells","volume":"53","author":"Anth\u00e9rieu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b1105","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1124\/dmd.110.036848","article-title":"CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload","volume":"39","author":"Madec","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.plipres.2015.05.002_b1110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-230X-12-20","article-title":"Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease","volume":"12","author":"Chavez-Tapia","year":"2012","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.plipres.2015.05.002_b1115","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/gut.2006.118059","article-title":"Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity","volume":"56","author":"Malhi","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.plipres.2015.05.002_b1120","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1096\/fasebj.13.14.1883","article-title":"Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells","volume":"13","author":"Bhatia","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.plipres.2015.05.002_b1125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11626-008-9166-1","article-title":"Maintaining hepatocyte differentiation in vitro through co-culture with hepatic stellate cells","volume":"45","author":"Krause","year":"2009","journal-title":"In Vitro Cell Dev. Biol. Anim."},{"key":"10.1016\/j.plipres.2015.05.002_b1130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nbt1361","article-title":"Microscale culture of human liver cells for drug development","volume":"26","author":"Khetani","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.plipres.2015.05.002_b1135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yexmp.2014.12.006","article-title":"The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation","volume":"98","author":"Giraudi","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.plipres.2015.05.002_b1140","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/cr.2009.73","article-title":"Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells","volume":"19","author":"Wobser","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.plipres.2015.05.002_b1145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M","article-title":"Controlling cell interactions by micropatterning in co-cultures: hepatocytes and 3T3 fibroblasts","volume":"34","author":"Bhatia","year":"1997","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.plipres.2015.05.002_b1150","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/jbt.21469","article-title":"Long-term stability of primary rat hepatocytes in micropatterned cocultures","volume":"27","author":"Ukairo","year":"2013","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.plipres.2015.05.002_b1155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/toxsci\/kfs326","article-title":"Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans","volume":"132","author":"Khetani","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.plipres.2015.05.002_b1160","article-title":"Hormone and drug-mediated modulation of glucose metabolism in a microscale model of the human liver","author":"Davidson","year":"2014","journal-title":"Tissue Eng. Part C Methods"},{"key":"10.1016\/j.plipres.2015.05.002_b1165","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1517\/17460441.2015.1032241","article-title":"The application of engineered liver tissues for novel drug discovery","volume":"10","author":"Lin","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.plipres.2015.05.002_b1170","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","article-title":"Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME","volume":"87","author":"Godoy","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.plipres.2015.05.002_b1175","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jhep.2013.07.019","article-title":"Rat hepatocyte culture model of macrosteatosis: effect of macrosteatosis induction and reversal on viability and liver-specific function","volume":"59","author":"Nativ","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b1180","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1124\/dmd.113.052415","article-title":"Transcriptomic hepatotoxicity signature of chlorpromazine after short- and long-term exposure in primary human sandwich cultures","volume":"41","author":"Parmentier","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.plipres.2015.05.002_b1185","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.114.059352","article-title":"Evaluation of in situ generated valproyl 1-O-\u03b2-acyl glucuronide in valproic acid toxicity in sandwich-cultured rat hepatocytes","author":"Surendradoss","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.plipres.2015.05.002_b1190","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/bit.23025","article-title":"Use of three-dimensional spheroids of hepatocyte-derived reporter cells to study the effects of intracellular fat accumulation and subsequent cytokine exposure","volume":"108","author":"Janorkar","year":"2011","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.plipres.2015.05.002_b1195","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jcb.21229","article-title":"Fat-loaded HepG2 spheroids exhibit enhanced protection from Pro-oxidant and cytokine induced damage","volume":"101","author":"Damelin","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.plipres.2015.05.002_b1200","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/bit.23349","article-title":"A novel 3D liver organoid system for elucidation of hepatic glucose metabolism","volume":"109","author":"Lu","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.plipres.2015.05.002_b1205","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1517\/17425255.3.6.879","article-title":"Precision-cut tissue slices as a tool to predict metabolism of novel drugs","volume":"3","author":"Graaf","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.plipres.2015.05.002_b1210","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00192.2014","article-title":"From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations","volume":"308","author":"Green","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.plipres.2015.05.002_b1215","doi-asserted-by":"crossref","first-page":"e86795","DOI":"10.1371\/journal.pone.0086795","article-title":"Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices","volume":"9","author":"Szalowska","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2015.05.002_b1220","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1194\/jlr.M037812","article-title":"CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob\/ob mice","volume":"54","author":"Nassir","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plipres.2015.05.002_b1225","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ab.2006.05.019","article-title":"Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells","volume":"356","author":"Tryndyak","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.plipres.2015.05.002_b1230","doi-asserted-by":"crossref","first-page":"e44345","DOI":"10.1371\/journal.pone.0044345","article-title":"Hepatic lipid accumulation alters global histone h3 lysine 9 and 4 trimethylation in the peroxisome proliferator-activated receptor alpha network","volume":"7","author":"Jun","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2015.05.002_b1235","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2012-302962","article-title":"Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease","volume":"62","author":"Pirola","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.plipres.2015.05.002_b1240","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/hep.23927","article-title":"Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b1 promoter","volume":"52","author":"Sookoian","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b1245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.plipres.2015.05.002_b1250","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/onc.2009.211","article-title":"Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties","volume":"28","author":"Coulouarn","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.plipres.2015.05.002_b1255","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.plipres.2015.05.002_b1260","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b1265","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis","author":"Pirola","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.plipres.2015.05.002_b1270","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","article-title":"Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver","volume":"424","author":"Yamada","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.plipres.2015.05.002_b1275","doi-asserted-by":"crossref","first-page":"e23937","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"Cermelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2015.05.002_b1280","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","article-title":"Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver","volume":"122","author":"Hsu","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plipres.2015.05.002_b1285","article-title":"A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver","author":"Mattis","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b1290","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/labinvest.2010.113","article-title":"Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice","volume":"90","author":"Pogribny","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.plipres.2015.05.002_b1295","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/labinvest.2010.166","article-title":"Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease","volume":"91","author":"Alisi","year":"2011","journal-title":"Lab. Invest."},{"key":"10.1016\/j.plipres.2015.05.002_b1300","doi-asserted-by":"crossref","first-page":"24154","DOI":"10.3390\/ijms141224154","article-title":"EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD","volume":"14","author":"Vella","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.plipres.2015.05.002_b1305","doi-asserted-by":"crossref","first-page":"527","DOI":"10.18632\/aging.100184","article-title":"Controlling SIRT1 expression by microRNAs in health and metabolic disease","volume":"2","author":"Lee","year":"2010","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.plipres.2015.05.002_b1310","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nature10112","article-title":"MicroRNAs 103 and 107 regulate insulin sensitivity","volume":"474","author":"Trajkovski","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2015.05.002_b1315","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/acel.12135","article-title":"Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT","volume":"12","author":"Choi","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.plipres.2015.05.002_b1320","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.plipres.2015.05.002_b1325","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hep.23759","article-title":"CRN N. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease","volume":"52","author":"Rotman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b1330","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2014.02.030","article-title":"Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma","volume":"61","author":"Liu","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b1335","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.plipres.2015.05.002_b1340","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/met.2013.0120","article-title":"TLR4 gene polymorphism in patients with nonalcoholic fatty liver disease in comparison to healthy controls","volume":"12","author":"Kiziltas","year":"2014","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.plipres.2015.05.002_b1345","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3945\/ajcn.113.063792","article-title":"Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism","volume":"98","author":"Musso","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plipres.2015.05.002_b1350","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jgh.12714","article-title":"A common variant in the glucokinase regulatory gene rs780094 and risk of nonalcoholic fatty liver disease: A meta-analysis","volume":"30","author":"Zain","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.plipres.2015.05.002_b1355","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/dna.2013.2238","article-title":"MTP-493G>T polymorphism and susceptibility to nonalcoholic fatty liver disease: a meta-analysis","volume":"33","author":"Zheng","year":"2014","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.plipres.2015.05.002_b1360","doi-asserted-by":"crossref","first-page":"e87523","DOI":"10.1371\/journal.pone.0087523","article-title":"Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease","volume":"9","author":"Petta","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2015.05.002_b1365","doi-asserted-by":"crossref","first-page":"14010","DOI":"10.3748\/wjg.v20.i38.14010","article-title":"Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population","volume":"20","author":"Li","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.plipres.2015.05.002_b1370","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ctrv.2013.07.006","article-title":"Omic-profiling in breast cancer metastasis to bone: implications for mechanisms, biomarkers and treatment","volume":"40","author":"Wood","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.plipres.2015.05.002_b1375","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1152\/physiolgenomics.90339.2008","article-title":"Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver","volume":"37","author":"Guill\u00e9n","year":"2009","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.plipres.2015.05.002_b1380","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/jcmm.12328","article-title":"Extracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice","volume":"18","author":"Hennig","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.plipres.2015.05.002_b1385","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/hep.26957","article-title":"Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPAR\u03b3","volume":"59","author":"Xu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b1390","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/labinvest.3700374","article-title":"Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray","volume":"86","author":"Chiappini","year":"2006","journal-title":"Lab. Invest."},{"key":"10.1016\/j.plipres.2015.05.002_b1395","doi-asserted-by":"crossref","first-page":"e46584","DOI":"10.1371\/journal.pone.0046584","article-title":"Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis","volume":"7","author":"Starmann","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2015.05.002_b1400","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.7314\/APJCP.2014.15.20.8529","article-title":"Research progress in applying proteomics technology to explore early diagnosis biomarkers of breast cancer, lung cancer and ovarian cancer","volume":"15","author":"Luo","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.plipres.2015.05.002_b1405","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.metabol.2008.03.017","article-title":"Proteomic analysis of fructose-induced fatty liver in hamsters","volume":"57","author":"Zhang","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.plipres.2015.05.002_b1410","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1002\/pmic.201000544","article-title":"Differential expression of intermediate filaments in the process of developing hepatic steatosis","volume":"11","author":"Park","year":"2011","journal-title":"Proteomics"},{"key":"10.1016\/j.plipres.2015.05.002_b1415","doi-asserted-by":"crossref","first-page":"14050","DOI":"10.1074\/jbc.M109.001107","article-title":"Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice","volume":"284","author":"Hui","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plipres.2015.05.002_b1420","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jprot.2011.03.003","article-title":"Proteomic analysis of changes in protein expression in liver mitochondria in apoE knockout mice","volume":"74","author":"Suski","year":"2011","journal-title":"J. Proteomics"},{"key":"10.1016\/j.plipres.2015.05.002_b1425","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/pmic.201100628","article-title":"Early changes in the liver-soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet","volume":"12","author":"Thomas","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.plipres.2015.05.002_b1430","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/pmic.201200210","article-title":"Proteomic and bioinformatic analysis of membrane proteome in type 2 diabetic mouse liver","volume":"13","author":"Kim","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.plipres.2015.05.002_b1435","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000336075","article-title":"Liver proteome changes induced by a short-term high-fat sucrose diet in wistar rats","volume":"4","author":"Bondia-Pons","year":"2011","journal-title":"J. Nutrigenet. Nutrigenomics"},{"key":"10.1016\/j.plipres.2015.05.002_b1440","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/hep.22927","article-title":"Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease","volume":"49","author":"Charlton","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b1445","doi-asserted-by":"crossref","first-page":"11437","DOI":"10.1073\/pnas.1410741111","article-title":"Comparative proteomic study reveals 17\u03b2-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease","volume":"111","author":"Su","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.plipres.2015.05.002_b1450","first-page":"63","article-title":"Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery","volume":"107C","author":"Patel","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.plipres.2015.05.002_b1455","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/msb.2009.18","article-title":"Metabolomics of the interaction between PPAR-alpha and age in the PPAR-alpha-null mouse","volume":"5","author":"Atherton","year":"2009","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.plipres.2015.05.002_b1460","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1021\/pr901203w","article-title":"Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease","volume":"9","author":"Vinaixa","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.plipres.2015.05.002_b1465","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1021\/pr100792q","article-title":"Systems responses of rats to aflatoxin B1 exposure revealed with metabonomic changes in multiple biological matrices","volume":"10","author":"Zhang","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.plipres.2015.05.002_b1470","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1152\/physiolgenomics.00179.2010","article-title":"Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention","volume":"43","author":"Rubio-Aliaga","year":"2011","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.plipres.2015.05.002_b1475","doi-asserted-by":"crossref","first-page":"e21187","DOI":"10.1371\/journal.pone.0021187","article-title":"Dietary leucine\u2014an environmental modifier of insulin resistance acting on multiple levels of metabolism","volume":"6","author":"Macotela","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2015.05.002_b1480","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1021\/pr400050u","article-title":"Paraoxonase-1 deficiency is associated with severe liver steatosis in mice fed a high-fat high-cholesterol diet: a metabolomic approach","volume":"12","author":"Garc\u00eda-Heredia","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.plipres.2015.05.002_b1485","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.25630","article-title":"Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis","volume":"56","author":"Tanaka","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b1490","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.bbalip.2014.08.015","article-title":"Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet","volume":"1841","author":"Tanaka","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plipres.2015.05.002_b1495","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.taap.2013.01.018","article-title":"Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats","volume":"268","author":"Yamazaki","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b1500","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1021\/pr200047c","article-title":"A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease","volume":"10","author":"Li","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.plipres.2015.05.002_b1505","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","article-title":"Plasma metabolomic profile in nonalcoholic fatty liver disease","volume":"60","author":"Kalhan","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.plipres.2015.05.002_b1510","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.taap.2013.01.022","article-title":"Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease","volume":"268","author":"Lake","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.plipres.2015.05.002_b1515","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1021\/pr200629p","article-title":"A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations","volume":"10","author":"Garc\u00eda-Ca\u00f1averas","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.plipres.2015.05.002_b1520","doi-asserted-by":"crossref","DOI":"10.1016\/j.cld.2013.07.012","article-title":"Drug-induced steatohepatitis","volume":"17","author":"Patel","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.plipres.2015.05.002_b1525","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","article-title":"Biomarkers: potential uses and limitations","volume":"1","author":"Mayeux","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.plipres.2015.05.002_b1530","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/oby.2007.608","article-title":"High-fat diets: modeling the metabolic disorders of human obesity in rodents","volume":"15","author":"Buettner","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.plipres.2015.05.002_b1535","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/scd.2013.0157","article-title":"Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals","volume":"23","author":"Rodrigues","year":"2014","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.plipres.2015.05.002_b1540","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.ajpath.2011.07.014","article-title":"Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis","volume":"179","author":"Itoh","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.plipres.2015.05.002_b1545","doi-asserted-by":"crossref","first-page":"G1333","DOI":"10.1152\/ajpgi.2001.281.6.G1333","article-title":"Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis","volume":"281","author":"Reddy","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.plipres.2015.05.002_b1550","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/path.2065","article-title":"Disrupted galectin-3 causes non-alcoholic fatty liver disease in male mice","volume":"210","author":"Nomoto","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.plipres.2015.05.002_b1555","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1172\/JCI12590","article-title":"Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death","volume":"107","author":"Ibdah","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plipres.2015.05.002_b1560","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.gastro.2005.02.001","article-title":"Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance","volume":"128","author":"Ibdah","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.plipres.2015.05.002_b1565","doi-asserted-by":"crossref","first-page":"24698","DOI":"10.1074\/jbc.271.40.24698","article-title":"Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene","volume":"271","author":"Fan","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plipres.2015.05.002_b1570","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI20513","article-title":"Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas","volume":"113","author":"Horie","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plipres.2015.05.002_b1575","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1096\/fj.02-0078fje","article-title":"Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A","volume":"16","author":"Mart\u00ednez-Chantar","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.plipres.2015.05.002_b1580","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1210\/en.2006-0708","article-title":"Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes","volume":"148","author":"Liu","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.plipres.2015.05.002_b1585","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nm1557","article-title":"Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions","volume":"13","author":"Yamauchi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.plipres.2015.05.002_b1590","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s00125-010-1865-y","article-title":"Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance","volume":"53","author":"Matthews","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.plipres.2015.05.002_b1595","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/jpet.108.144600","article-title":"Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet","volume":"328","author":"Kong","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.plipres.2015.05.002_b1600","doi-asserted-by":"crossref","first-page":"G1205","DOI":"10.1152\/ajpgi.00157.2007","article-title":"The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis","volume":"293","author":"Goel","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.plipres.2015.05.002_b1605","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1053\/j.gastro.2005.02.034","article-title":"Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver","volume":"128","author":"Robert","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.plipres.2015.05.002_b1610","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.21641","article-title":"Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa\/fa rats","volume":"46","author":"Gary-Bobo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2015.05.002_b1615","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1194\/jlr.M200169-JLR200","article-title":"Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone","volume":"43","author":"Watkins","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plipres.2015.05.002_b1620","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbalip.2007.07.007","article-title":"Metabolomics (liver and blood profiling) in a mouse model in response to fasting: a study of hepatic steatosis","volume":"1771","author":"van Ginneken","year":"2007","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Progress in Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782715000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782715000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T16:28:09Z","timestamp":1748449689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163782715000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":324,"alternative-id":["S0163782715000260"],"URL":"https:\/\/doi.org\/10.1016\/j.plipres.2015.05.002","relation":{},"ISSN":["0163-7827"],"issn-type":[{"value":"0163-7827","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research","name":"articletitle","label":"Article Title"},{"value":"Progress in Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plipres.2015.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}